景峰医药 (000908.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(景峰医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 173,311,877.00204,465,796.66176,056,130.03228,835,490.40209,812,385.67220,606,401.57181,402,884.35
 营业收入(元) 173,311,877.00204,465,796.66176,056,130.03228,835,490.40209,812,385.67220,606,401.57181,402,884.35
二、营业总成本(元) 187,889,039.32211,014,016.77168,775,870.62280,292,848.02218,643,481.23221,901,246.03170,714,929.26
 营业成本(元) 50,725,048.5844,866,472.1539,763,582.4263,366,857.5049,071,898.7851,148,978.0736,079,716.50
 研发费用(元) 3,890,693.485,077,315.795,099,494.0916,241,130.149,317,385.015,209,258.334,875,944.05
 营业税金及附加(元) 3,611,563.363,136,437.762,042,021.923,347,530.002,916,723.843,899,844.432,162,840.89
 销售费用(元) 84,892,069.10104,903,161.1884,437,696.09119,435,521.55104,336,648.17112,855,785.0185,251,973.55
 管理费用(元) 36,227,048.8443,625,862.9027,890,733.4264,143,798.0440,323,386.6036,698,338.9629,571,542.47
 财务费用(元) 8,542,615.969,404,766.999,542,342.6813,758,010.7912,677,438.8312,089,041.2312,772,911.80
  其中:利息费用(元) 9,729,443.8810,609,534.998,223,602.2114,581,431.7412,610,963.7412,340,539.5012,871,451.01
  其中:利息收入(元) 537,780.09331,793.15224,760.67349,850.23347,208.40227,826.42196,618.56
 资产减值损失(元) -1,515,948.571,566,198.011,842.95-50,003,355.22-795,962.65-347,028.025,867,891.03
 信用减值损失(元) -2,441,461.80350,412.373,508,864.58-15,509,983.61899,893.40-502,177.352,470,215.64
三、其他经营收益
 加:投资收益(元) -4,187.25-709,377.10-22,989.16-2,812,680.08-71,527.46--
  其中:对联营企业和合营企业的投资收益(元) -4,187.25-691,054.96-41,311.31-2,786,209.40-71,527.46--
 资产处置收益(元) 216,983.34-176,363.73-415,969.655,632,637.91-6,802.43-223,463.38-98,050.78
 其他收益(元) 1,537,698.519,181,657.85573,517.742,178,091.242,997,923.396,106,450.725,168,481.53
四、营业利润(元) -16,784,078.093,664,307.2910,925,525.87-94,062,073.56-5,807,571.312,533,282.5424,096,492.51
 加:营业外收入(元) 191,693.7986,817.0470,463.69493,902.02258,227.7614,722.5742,110.43
 减:营业外支出(元) 304,908.344,510,639.78319,466.097,777,605.071,755,965.031,691,612.786,898,999.53
五、利润总额(元) -16,897,292.64-759,515.4510,676,523.47-101,345,776.61-7,305,308.58856,392.3317,239,603.41
 减:所得税费用(元) 2,885,190.362,388,952.401,933,272.52-1,107,567.405,502,574.83864,425.345,072,643.31
六、净利润(元) -19,782,483.00-3,148,467.858,743,250.95-100,238,209.21-12,807,883.41-8,033.0112,166,960.10
(一)按经营持续性分类
  持续经营净利润(元) -19,782,483.00-3,148,467.858,743,250.95-100,238,209.21-12,807,883.41-8,033.0112,166,960.10
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -22,620,211.06-14,124,271.051,278,629.96-98,405,880.41-18,294,564.77-14,800,485.473,338,005.22
  少数股东损益(元) 2,837,728.0610,975,803.207,464,620.99-1,832,328.805,486,681.3614,792,452.468,828,954.88
 扣除非经常性损益后的净利润(元) -23,595,170.56-20,052,184.42634,895.22-116,826,804.59-19,433,154.71-16,976,365.093,514,404.31
七、每股收益
 一、基本每股收益(元) -0.03-0.02--0.11-0.02-0.02-
 二、稀释每股收益(元) -0.03-0.02--0.11-0.02-0.02-
八、其他综合收益(元) -388,126.791,360,014.60-601,135.13-1,303,205.63-381,595.68--
 归属于母公司股东的其他综合收益(元) -197,944.66693,607.45-306,578.92-720,847.80-194,613.80--
 归属于少数股东的其他综合收益(元) -190,182.13666,407.15-294,556.21-582,357.83-186,981.88--
九、综合收益总额(元) -20,170,609.79-1,788,453.258,142,115.82-101,541,414.84-13,189,479.09552,093.3412,166,960.10
 归属于母公司所有者的综合收益总额(元) -22,818,155.72-13,430,663.60972,051.04-99,126,728.21-18,489,178.57-14,514,821.033,338,005.22
 归属于少数股东的综合收益总额(元) 2,647,545.9311,642,210.357,170,064.78-2,414,686.635,299,699.4815,066,914.378,828,954.88
公告日期 2023-10-312023-08-282023-04-292023-04-292022-10-312022-08-302022-04-30
审计意见(境内) 保留意见

前瞻产业研究院